Apollo Medical Holdings (AMEH) Tops Q3 EPS by 14c; Offers FY23 Guidance

Apollo Medical Holdings, Inc. (NASDAQ: AMEH) reported Q3 EPS of $0.47, $0.14 better than the analyst estimate of $0.33. Revenue for the quarter came in at $348.2 million versus the consensus estimate of $350.1 million.

GUIDANCE:

Apollo Medical Holdings, Inc. sees FY2023 EPS of $1.10-$1.20, versus the consensus of $1.28. Apollo Medical Holdings, Inc. sees FY2023 revenue of $1.34-1.39 billion, versus the consensus of $1.39 billion.

For earnings history and earnings-related data on Apollo Medical Holdings, Inc. (AMEH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c